Typicality: | 0.320 |
Saliency: | 0.164 |
vaccine → be developed by → pharmaceutical company | 4 |
vaccine → be developed by → british pharmaceutical company | 3 |
vaccine → be developed by → company | 3 |
negative | neutral | positive |
0.066 | 0.638 | 0.296 |
Raw frequency | 10 |
Normalized frequency | 0.164 |
Modifier score | 0.500 |
Perplexity | 80.067 |